Precision Cancer Diagnostic Tests Market, Global Outlook and Forecast 2023-2028

Report ID: 1568401 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Precision Cancer Diagnostic Tests Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Precision Cancer Diagnostic Tests Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Precision Cancer Diagnostic Tests Overall Market Size
    2.1 Global Precision Cancer Diagnostic Tests Market Size: 2021 VS 2028
    2.2 Global Precision Cancer Diagnostic Tests Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Precision Cancer Diagnostic Tests Players in Global Market
    3.2 Top Global Precision Cancer Diagnostic Tests Companies Ranked by Revenue
    3.3 Global Precision Cancer Diagnostic Tests Revenue by Companies
    3.4 Top 3 and Top 5 Precision Cancer Diagnostic Tests Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Precision Cancer Diagnostic Tests Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Precision Cancer Diagnostic Tests Players in Global Market
        3.6.1 List of Global Tier 1 Precision Cancer Diagnostic Tests Companies
        3.6.2 List of Global Tier 2 and Tier 3 Precision Cancer Diagnostic Tests Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Precision Cancer Diagnostic Tests Market Size Markets, 2021 & 2028
        4.1.2 Imaging
        4.1.3 Molecular
        4.1.4 Histology/Cytology
        4.1.5 Tumor Marker Immunoassays
        4.1.6 POC Colon Cancer Tests
    4.2 By Type - Global Precision Cancer Diagnostic Tests Revenue & Forecasts
        4.2.1 By Type - Global Precision Cancer Diagnostic Tests Revenue, 2017-2022
        4.2.2 By Type - Global Precision Cancer Diagnostic Tests Revenue, 2023-2028
        4.2.3 By Type - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Precision Cancer Diagnostic Tests Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Clinic
        5.1.4 Other
    5.2 By Application - Global Precision Cancer Diagnostic Tests Revenue & Forecasts
        5.2.1 By Application - Global Precision Cancer Diagnostic Tests Revenue, 2017-2022
        5.2.2 By Application - Global Precision Cancer Diagnostic Tests Revenue, 2023-2028
        5.2.3 By Application - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Precision Cancer Diagnostic Tests Market Size, 2021 & 2028
    6.2 By Region - Global Precision Cancer Diagnostic Tests Revenue & Forecasts
        6.2.1 By Region - Global Precision Cancer Diagnostic Tests Revenue, 2017-2022
        6.2.2 By Region - Global Precision Cancer Diagnostic Tests Revenue, 2023-2028
        6.2.3 By Region - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Precision Cancer Diagnostic Tests Revenue, 2017-2028
        6.3.2 US Precision Cancer Diagnostic Tests Market Size, 2017-2028
        6.3.3 Canada Precision Cancer Diagnostic Tests Market Size, 2017-2028
        6.3.4 Mexico Precision Cancer Diagnostic Tests Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Precision Cancer Diagnostic Tests Revenue, 2017-2028
        6.4.2 Germany Precision Cancer Diagnostic Tests Market Size, 2017-2028
        6.4.3 France Precision Cancer Diagnostic Tests Market Size, 2017-2028
        6.4.4 U.K. Precision Cancer Diagnostic Tests Market Size, 2017-2028
        6.4.5 Italy Precision Cancer Diagnostic Tests Market Size, 2017-2028
        6.4.6 Russia Precision Cancer Diagnostic Tests Market Size, 2017-2028
        6.4.7 Nordic Countries Precision Cancer Diagnostic Tests Market Size, 2017-2028
        6.4.8 Benelux Precision Cancer Diagnostic Tests Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Precision Cancer Diagnostic Tests Revenue, 2017-2028
        6.5.2 China Precision Cancer Diagnostic Tests Market Size, 2017-2028
        6.5.3 Japan Precision Cancer Diagnostic Tests Market Size, 2017-2028
        6.5.4 South Korea Precision Cancer Diagnostic Tests Market Size, 2017-2028
        6.5.5 Southeast Asia Precision Cancer Diagnostic Tests Market Size, 2017-2028
        6.5.6 India Precision Cancer Diagnostic Tests Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Precision Cancer Diagnostic Tests Revenue, 2017-2028
        6.6.2 Brazil Precision Cancer Diagnostic Tests Market Size, 2017-2028
        6.6.3 Argentina Precision Cancer Diagnostic Tests Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Precision Cancer Diagnostic Tests Revenue, 2017-2028
        6.7.2 Turkey Precision Cancer Diagnostic Tests Market Size, 2017-2028
        6.7.3 Israel Precision Cancer Diagnostic Tests Market Size, 2017-2028
        6.7.4 Saudi Arabia Precision Cancer Diagnostic Tests Market Size, 2017-2028
        6.7.5 UAE Precision Cancer Diagnostic Tests Market Size, 2017-2028
7 Players Profiles
    7.1 Abbott Laboratories
        7.1.1 Abbott Laboratories Corporate Summary
        7.1.2 Abbott Laboratories Business Overview
        7.1.3 Abbott Laboratories Precision Cancer Diagnostic Tests Major Product Offerings
        7.1.4 Abbott Laboratories Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.1.5 Abbott Laboratories Key News
    7.2 Agilent Technologies
        7.2.1 Agilent Technologies Corporate Summary
        7.2.2 Agilent Technologies Business Overview
        7.2.3 Agilent Technologies Precision Cancer Diagnostic Tests Major Product Offerings
        7.2.4 Agilent Technologies Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.2.5 Agilent Technologies Key News
    7.3 Becton Dickinson and Company
        7.3.1 Becton Dickinson and Company Corporate Summary
        7.3.2 Becton Dickinson and Company Business Overview
        7.3.3 Becton Dickinson and Company Precision Cancer Diagnostic Tests Major Product Offerings
        7.3.4 Becton Dickinson and Company Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.3.5 Becton Dickinson and Company Key News
    7.4 Bio-Rad Laboratories
        7.4.1 Bio-Rad Laboratories Corporate Summary
        7.4.2 Bio-Rad Laboratories Business Overview
        7.4.3 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Major Product Offerings
        7.4.4 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.4.5 Bio-Rad Laboratories Key News
    7.5 Biocartis N.V.
        7.5.1 Biocartis N.V. Corporate Summary
        7.5.2 Biocartis N.V. Business Overview
        7.5.3 Biocartis N.V. Precision Cancer Diagnostic Tests Major Product Offerings
        7.5.4 Biocartis N.V. Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.5.5 Biocartis N.V. Key News
    7.6 Biocept
        7.6.1 Biocept Corporate Summary
        7.6.2 Biocept Business Overview
        7.6.3 Biocept Precision Cancer Diagnostic Tests Major Product Offerings
        7.6.4 Biocept Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.6.5 Biocept Key News
    7.7 bioMerieux SA
        7.7.1 bioMerieux SA Corporate Summary
        7.7.2 bioMerieux SA Business Overview
        7.7.3 bioMerieux SA Precision Cancer Diagnostic Tests Major Product Offerings
        7.7.4 bioMerieux SA Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.7.5 bioMerieux SA Key News
    7.8 Canon Medical Systems Corporation
        7.8.1 Canon Medical Systems Corporation Corporate Summary
        7.8.2 Canon Medical Systems Corporation Business Overview
        7.8.3 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Major Product Offerings
        7.8.4 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.8.5 Canon Medical Systems Corporation Key News
    7.9 Cynvenio Biosystems
        7.9.1 Cynvenio Biosystems Corporate Summary
        7.9.2 Cynvenio Biosystems Business Overview
        7.9.3 Cynvenio Biosystems Precision Cancer Diagnostic Tests Major Product Offerings
        7.9.4 Cynvenio Biosystems Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.9.5 Cynvenio Biosystems Key News
    7.10 Danaher Corporation
        7.10.1 Danaher Corporation Corporate Summary
        7.10.2 Danaher Corporation Business Overview
        7.10.3 Danaher Corporation Precision Cancer Diagnostic Tests Major Product Offerings
        7.10.4 Danaher Corporation Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.10.5 Danaher Corporation Key News
    7.11 Epigenomics AG
        7.11.1 Epigenomics AG Corporate Summary
        7.11.2 Epigenomics AG Business Overview
        7.11.3 Epigenomics AG Precision Cancer Diagnostic Tests Major Product Offerings
        7.11.4 Epigenomics AG Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.11.5 Epigenomics AG Key News
    7.12 Exosome Diagnostics
        7.12.1 Exosome Diagnostics Corporate Summary
        7.12.2 Exosome Diagnostics Business Overview
        7.12.3 Exosome Diagnostics Precision Cancer Diagnostic Tests Major Product Offerings
        7.12.4 Exosome Diagnostics Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.12.5 Exosome Diagnostics Key News
    7.13 Foundation Medicine
        7.13.1 Foundation Medicine Corporate Summary
        7.13.2 Foundation Medicine Business Overview
        7.13.3 Foundation Medicine Precision Cancer Diagnostic Tests Major Product Offerings
        7.13.4 Foundation Medicine Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.13.5 Foundation Medicine Key News
    7.14 General Electric Company
        7.14.1 General Electric Company Corporate Summary
        7.14.2 General Electric Company Business Overview
        7.14.3 General Electric Company Precision Cancer Diagnostic Tests Major Product Offerings
        7.14.4 General Electric Company Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.14.5 General Electric Company Key News
    7.15 Genomic Health
        7.15.1 Genomic Health Corporate Summary
        7.15.2 Genomic Health Business Overview
        7.15.3 Genomic Health Precision Cancer Diagnostic Tests Major Product Offerings
        7.15.4 Genomic Health Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.15.5 Genomic Health Key News
    7.16 Hologic
        7.16.1 Hologic Corporate Summary
        7.16.2 Hologic Business Overview
        7.16.3 Hologic Precision Cancer Diagnostic Tests Major Product Offerings
        7.16.4 Hologic Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.16.5 Hologic Key News
    7.17 Illumina
        7.17.1 Illumina Corporate Summary
        7.17.2 Illumina Business Overview
        7.17.3 Illumina Precision Cancer Diagnostic Tests Major Product Offerings
        7.17.4 Illumina Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.17.5 Illumina Key News
    7.18 Menarini Silicon Biosystems SpA
        7.18.1 Menarini Silicon Biosystems SpA Corporate Summary
        7.18.2 Menarini Silicon Biosystems SpA Business Overview
        7.18.3 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Major Product Offerings
        7.18.4 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.18.5 Menarini Silicon Biosystems SpA Key News
    7.19 Myriad Genetics
        7.19.1 Myriad Genetics Corporate Summary
        7.19.2 Myriad Genetics Business Overview
        7.19.3 Myriad Genetics Precision Cancer Diagnostic Tests Major Product Offerings
        7.19.4 Myriad Genetics Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.19.5 Myriad Genetics Key News
    7.20 NanoString Technologies
        7.20.1 NanoString Technologies Corporate Summary
        7.20.2 NanoString Technologies Business Overview
        7.20.3 NanoString Technologies Precision Cancer Diagnostic Tests Major Product Offerings
        7.20.4 NanoString Technologies Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.20.5 NanoString Technologies Key News
    7.21 Ortho Clinical Diagnostics
        7.21.1 Ortho Clinical Diagnostics Corporate Summary
        7.21.2 Ortho Clinical Diagnostics Business Overview
        7.21.3 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Major Product Offerings
        7.21.4 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.21.5 Ortho Clinical Diagnostics Key News
    7.22 QIAGEN N.V.
        7.22.1 QIAGEN N.V. Corporate Summary
        7.22.2 QIAGEN N.V. Business Overview
        7.22.3 QIAGEN N.V. Precision Cancer Diagnostic Tests Major Product Offerings
        7.22.4 QIAGEN N.V. Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.22.5 QIAGEN N.V. Key News
    7.23 Randox Laboratories Ltd.
        7.23.1 Randox Laboratories Ltd. Corporate Summary
        7.23.2 Randox Laboratories Ltd. Business Overview
        7.23.3 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Major Product Offerings
        7.23.4 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.23.5 Randox Laboratories Ltd. Key News
    7.24 Roche Holding AG
        7.24.1 Roche Holding AG Corporate Summary
        7.24.2 Roche Holding AG Business Overview
        7.24.3 Roche Holding AG Precision Cancer Diagnostic Tests Major Product Offerings
        7.24.4 Roche Holding AG Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.24.5 Roche Holding AG Key News
    7.25 Royal Philips N.V.
        7.25.1 Royal Philips N.V. Corporate Summary
        7.25.2 Royal Philips N.V. Business Overview
        7.25.3 Royal Philips N.V. Precision Cancer Diagnostic Tests Major Product Offerings
        7.25.4 Royal Philips N.V. Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.25.5 Royal Philips N.V. Key News
    7.26 Siemens AG
        7.26.1 Siemens AG Corporate Summary
        7.26.2 Siemens AG Business Overview
        7.26.3 Siemens AG Precision Cancer Diagnostic Tests Major Product Offerings
        7.26.4 Siemens AG Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.26.5 Siemens AG Key News
    7.27 Thermo Fisher Scientific
        7.27.1 Thermo Fisher Scientific Corporate Summary
        7.27.2 Thermo Fisher Scientific Business Overview
        7.27.3 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Major Product Offerings
        7.27.4 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.27.5 Thermo Fisher Scientific Key News
    7.28 Vela Diagnostics
        7.28.1 Vela Diagnostics Corporate Summary
        7.28.2 Vela Diagnostics Business Overview
        7.28.3 Vela Diagnostics Precision Cancer Diagnostic Tests Major Product Offerings
        7.28.4 Vela Diagnostics Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
        7.28.5 Vela Diagnostics Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Precision Cancer Diagnostic Tests Market Opportunities & Trends in Global Market
    Table 2. Precision Cancer Diagnostic Tests Market Drivers in Global Market
    Table 3. Precision Cancer Diagnostic Tests Market Restraints in Global Market
    Table 4. Key Players of Precision Cancer Diagnostic Tests in Global Market
    Table 5. Top Precision Cancer Diagnostic Tests Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Precision Cancer Diagnostic Tests Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Precision Cancer Diagnostic Tests Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Precision Cancer Diagnostic Tests Product Type
    Table 9. List of Global Tier 1 Precision Cancer Diagnostic Tests Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Precision Cancer Diagnostic Tests Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Precision Cancer Diagnostic Tests Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Precision Cancer Diagnostic Tests Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Precision Cancer Diagnostic Tests Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Precision Cancer Diagnostic Tests Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Precision Cancer Diagnostic Tests Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Precision Cancer Diagnostic Tests Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2023-2028
    Table 30. Abbott Laboratories Corporate Summary
    Table 31. Abbott Laboratories Precision Cancer Diagnostic Tests Product Offerings
    Table 32. Abbott Laboratories Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 33. Agilent Technologies Corporate Summary
    Table 34. Agilent Technologies Precision Cancer Diagnostic Tests Product Offerings
    Table 35. Agilent Technologies Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 36. Becton Dickinson and Company Corporate Summary
    Table 37. Becton Dickinson and Company Precision Cancer Diagnostic Tests Product Offerings
    Table 38. Becton Dickinson and Company Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 39. Bio-Rad Laboratories Corporate Summary
    Table 40. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Offerings
    Table 41. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 42. Biocartis N.V. Corporate Summary
    Table 43. Biocartis N.V. Precision Cancer Diagnostic Tests Product Offerings
    Table 44. Biocartis N.V. Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 45. Biocept Corporate Summary
    Table 46. Biocept Precision Cancer Diagnostic Tests Product Offerings
    Table 47. Biocept Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 48. bioMerieux SA Corporate Summary
    Table 49. bioMerieux SA Precision Cancer Diagnostic Tests Product Offerings
    Table 50. bioMerieux SA Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 51. Canon Medical Systems Corporation Corporate Summary
    Table 52. Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product Offerings
    Table 53. Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 54. Cynvenio Biosystems Corporate Summary
    Table 55. Cynvenio Biosystems Precision Cancer Diagnostic Tests Product Offerings
    Table 56. Cynvenio Biosystems Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 57. Danaher Corporation Corporate Summary
    Table 58. Danaher Corporation Precision Cancer Diagnostic Tests Product Offerings
    Table 59. Danaher Corporation Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 60. Epigenomics AG Corporate Summary
    Table 61. Epigenomics AG Precision Cancer Diagnostic Tests Product Offerings
    Table 62. Epigenomics AG Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 63. Exosome Diagnostics Corporate Summary
    Table 64. Exosome Diagnostics Precision Cancer Diagnostic Tests Product Offerings
    Table 65. Exosome Diagnostics Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 66. Foundation Medicine Corporate Summary
    Table 67. Foundation Medicine Precision Cancer Diagnostic Tests Product Offerings
    Table 68. Foundation Medicine Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 69. General Electric Company Corporate Summary
    Table 70. General Electric Company Precision Cancer Diagnostic Tests Product Offerings
    Table 71. General Electric Company Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 72. Genomic Health Corporate Summary
    Table 73. Genomic Health Precision Cancer Diagnostic Tests Product Offerings
    Table 74. Genomic Health Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 75. Hologic Corporate Summary
    Table 76. Hologic Precision Cancer Diagnostic Tests Product Offerings
    Table 77. Hologic Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 78. Illumina Corporate Summary
    Table 79. Illumina Precision Cancer Diagnostic Tests Product Offerings
    Table 80. Illumina Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 81. Menarini Silicon Biosystems SpA Corporate Summary
    Table 82. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product Offerings
    Table 83. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 84. Myriad Genetics Corporate Summary
    Table 85. Myriad Genetics Precision Cancer Diagnostic Tests Product Offerings
    Table 86. Myriad Genetics Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 87. NanoString Technologies Corporate Summary
    Table 88. NanoString Technologies Precision Cancer Diagnostic Tests Product Offerings
    Table 89. NanoString Technologies Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 90. Ortho Clinical Diagnostics Corporate Summary
    Table 91. Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product Offerings
    Table 92. Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 93. QIAGEN N.V. Corporate Summary
    Table 94. QIAGEN N.V. Precision Cancer Diagnostic Tests Product Offerings
    Table 95. QIAGEN N.V. Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 96. Randox Laboratories Ltd. Corporate Summary
    Table 97. Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product Offerings
    Table 98. Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 99. Roche Holding AG Corporate Summary
    Table 100. Roche Holding AG Precision Cancer Diagnostic Tests Product Offerings
    Table 101. Roche Holding AG Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 102. Royal Philips N.V. Corporate Summary
    Table 103. Royal Philips N.V. Precision Cancer Diagnostic Tests Product Offerings
    Table 104. Royal Philips N.V. Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 105. Siemens AG Corporate Summary
    Table 106. Siemens AG Precision Cancer Diagnostic Tests Product Offerings
    Table 107. Siemens AG Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 108. Thermo Fisher Scientific Corporate Summary
    Table 109. Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product Offerings
    Table 110. Thermo Fisher Scientific Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
    Table 111. Vela Diagnostics Corporate Summary
    Table 112. Vela Diagnostics Precision Cancer Diagnostic Tests Product Offerings
    Table 113. Vela Diagnostics Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Precision Cancer Diagnostic Tests Segment by Type in 2021
    Figure 2. Precision Cancer Diagnostic Tests Segment by Application in 2021
    Figure 3. Global Precision Cancer Diagnostic Tests Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Precision Cancer Diagnostic Tests Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Precision Cancer Diagnostic Tests Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Precision Cancer Diagnostic Tests Revenue in 2021
    Figure 8. By Type - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
    Figure 12. US Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
    Figure 16. Germany Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
    Figure 17. France Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
    Figure 24. China Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
    Figure 28. India Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
    Figure 30. Brazil Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
    Figure 33. Turkey Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
    Figure 37. Abbott Laboratories Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Agilent Technologies Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Becton Dickinson and Company Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Biocartis N.V. Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Biocept Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. bioMerieux SA Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Cynvenio Biosystems Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Danaher Corporation Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Epigenomics AG Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Exosome Diagnostics Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Foundation Medicine Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. General Electric Company Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. Genomic Health Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 52. Hologic Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 53. Illumina Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 54. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 55. Myriad Genetics Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 56. NanoString Technologies Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 57. Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 58. QIAGEN N.V. Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 59. Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 60. Roche Holding AG Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 61. Royal Philips N.V. Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 62. Siemens AG Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 63. Thermo Fisher Scientific Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 64. Vela Diagnostics Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
110
Frequently Asked Questions
Precision Cancer Diagnostic Tests Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Precision Cancer Diagnostic Tests Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Precision Cancer Diagnostic Tests Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Doctor's Bag Market

A medical bag (doctor's bag, physician's bag) is a portable bag used by a physician or other medi ... Read More

Medical Bag Market

A medical bag (doctor's bag, physician's bag) is a portable bag used by a physician or other medi ... Read More